Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies Journal Article
| Authors: | Lin, R. J.; Elko, T. A.; Devlin, S. M.; Shahrokni, A.; Jakubowski, A. A.; Dahi, P. B.; Perales, M. A.; Tamari, R.; Shaffer, B. C.; Sauter, C. S.; Papadopoulos, E. B.; Gyurkocza, B.; Korc-Grodzicki, B.; Barker, J. N.; Maloy, M. A.; Giralt, S. A. |
| Article Title: | Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies |
| Abstract: | Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR = 1.82; 95% CI, 1.04–3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes. © 2019, The Author(s), under exclusive licence to Springer Nature Limited. |
| Keywords: | adult; cancer survival; aged; human cell; major clinical study; overall survival; cancer recurrence; preoperative evaluation; clinical assessment; data base; cancer mortality; age; disease severity; hematologic malignancy; allogeneic hematopoietic stem cell transplantation; daily life activity; mood disorder; immunosuppressive agent; geriatric assessment; functional disease; kidney dysfunction; clinical outcome; walking difficulty; biochemical composition; hematological parameters; cancer prognosis; nutritional disorder; human; male; female; priority journal; article |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 55 |
| Issue: | 1 |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2020-01-01 |
| Start Page: | 157 |
| End Page: | 164 |
| Language: | English |
| DOI: | 10.1038/s41409-019-0654-6 |
| PUBMED: | 31471572 |
| PROVIDER: | scopus |
| PMCID: | PMC6940509 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work